PMID 40789979 - a more recent review summarising regenerative potential and interpretive caveats
All other evidence is from rodent and in vitro models
The methylcobalamin form in particular shows nerve-repairing properties, and has been shown to reduce homocysteine levels, treat peripheral neuropathy, ALS, multiple sclerosis, Alzheimer, Bells palsy, and other neurological disorders
Alternatively, a BPC-157 dosage of 400600 mcg/day has proven to be effective when administered via subcutaneous injection in close proximity to the affected region
Why 2 mL is the default: it produces whole-number unit readings at the most commonly researched doses, which removes the guesswork from drawing a partial tick mark
Both routes are used across Olympias wellness and performance protocols